|
Inari Medical, Inc. (Nari) DCF -Bewertung
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Inari Medical, Inc. (NARI) Bundle
Gewinnen Sie Einblicke in Ihre Inari Medical, Inc. (NARI) Bewertungsanalyse unter Verwendung unseres ausgeklügelten DCF -Taschenrechners! Diese Excel -Vorlage, die mit relevanten (Nari-) Daten vorinstalliert ist, ermöglicht es Ihnen, Vorhersagen und Annahmen anzupassen und eine genaue Berechnung des intrinsischen Wertes von Inari Medical zu ermöglichen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 51.1 | 139.7 | 277.0 | 383.5 | 493.6 | 821.3 | 1,366.3 | 2,273.2 | 3,782.0 | 6,292.1 |
| Revenue Growth, % | 0 | 173.17 | 98.31 | 38.45 | 28.73 | 66.37 | 66.37 | 66.37 | 66.37 | 66.37 |
| EBITDA | .4 | 16.4 | 15.5 | -18.3 | 15.2 | 26.9 | 44.7 | 74.4 | 123.8 | 205.9 |
| EBITDA, % | 0.70049 | 11.75 | 5.6 | -4.76 | 3.08 | 3.27 | 3.27 | 3.27 | 3.27 | 3.27 |
| Depreciation | .6 | 1.5 | 4.5 | 7.6 | 10.7 | 13.3 | 22.1 | 36.8 | 61.2 | 101.9 |
| Depreciation, % | 1.23 | 1.06 | 1.64 | 1.99 | 2.17 | 1.62 | 1.62 | 1.62 | 1.62 | 1.62 |
| EBIT | -.3 | 14.9 | 11.0 | -25.9 | 4.5 | 13.6 | 22.6 | 37.6 | 62.5 | 104.1 |
| EBIT, % | -0.53075 | 10.69 | 3.96 | -6.75 | 0.90189 | 1.65 | 1.65 | 1.65 | 1.65 | 1.65 |
| Total Cash | 23.6 | 164.2 | 176.1 | 326.4 | 115.5 | 522.8 | 869.9 | 1,447.2 | 2,407.7 | 4,005.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 11.3 | 28.0 | 42.4 | 58.6 | 70.1 | 142.8 | 237.6 | 395.3 | 657.6 | 1,094.0 |
| Account Receivables, % | 22.1 | 20.05 | 15.29 | 15.28 | 14.2 | 17.39 | 17.39 | 17.39 | 17.39 | 17.39 |
| Inventories | 4.0 | 10.6 | 21.1 | 32.6 | 42.9 | 65.9 | 109.6 | 182.3 | 303.4 | 504.7 |
| Inventories, % | 7.73 | 7.59 | 7.6 | 8.5 | 8.69 | 8.02 | 8.02 | 8.02 | 8.02 | 8.02 |
| Accounts Payable | 2.5 | 3.0 | 6.5 | 7.7 | 10.6 | 22.5 | 37.4 | 62.1 | 103.4 | 172.0 |
| Accounts Payable, % | 4.99 | 2.18 | 2.36 | 2 | 2.14 | 2.73 | 2.73 | 2.73 | 2.73 | 2.73 |
| Capital Expenditure | -3.1 | -5.5 | -13.6 | -10.0 | -6.2 | -30.9 | -51.5 | -85.6 | -142.5 | -237.0 |
| Capital Expenditure, % | -6.15 | -3.91 | -4.93 | -2.59 | -1.26 | -3.77 | -3.77 | -3.77 | -3.77 | -3.77 |
| Tax Rate, % | 138.53 | 138.53 | 138.53 | 138.53 | 138.53 | 138.53 | 138.53 | 138.53 | 138.53 | 138.53 |
| EBITAT | -.4 | 14.9 | 10.1 | -28.9 | -1.7 | 10.7 | 17.7 | 29.5 | 49.0 | 81.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -15.7 | -11.9 | -20.3 | -57.9 | -16.1 | -90.8 | -135.2 | -225.0 | -374.3 | -622.7 |
| WACC, % | 9.19 | 9.19 | 9.19 | 9.19 | 9.16 | 9.18 | 9.18 | 9.18 | 9.18 | 9.18 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1,034.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -635 | |||||||||
| Terminal Value | -8,845 | |||||||||
| Present Terminal Value | -5,701 | |||||||||
| Enterprise Value | -6,735 | |||||||||
| Net Debt | -7 | |||||||||
| Equity Value | -6,729 | |||||||||
| Diluted Shares Outstanding, MM | 57 | |||||||||
| Equity Value Per Share | -118.52 |
What You Will Receive
- Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-filled real NARI financial data.
- Actual Market Data: Historical performance metrics and forward-looking projections (highlighted in the yellow cells).
- Assumption Flexibility: Adjust forecast parameters such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe how your inputs affect Inari Medical's valuation.
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for clarity and user-friendliness, complete with step-by-step guidance.
Key Features
- 🔍 Real-Life NARI Financials: Pre-filled historical and projected data for Inari Medical, Inc. (NARI).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Inari Medical's intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Inari Medical's valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Inari Medical’s pre-filled financial data and forecasts.
- Step 3: Modify critical inputs like revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Watch the DCF model update instantly as you tweak assumptions.
- Step 5: Analyze the outputs and use the results for investment decisions.
Why Choose This Calculator for Inari Medical, Inc. (NARI)?
- Comprehensive Tool: Offers a complete package including DCF, WACC, and financial ratio analyses.
- Customizable Inputs: Modify the yellow-highlighted cells to explore different scenarios.
- Detailed Insights: Automatically computes Inari Medical’s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable starting points.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focused on Inari Medical, Inc. (NARI).
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for assessing Inari Medical, Inc. (NARI) stock.
- Medical Device Teams: Evaluate valuation scenarios to inform product development strategies.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Inari Medical, Inc. (NARI).
- Students and Educators: Utilize real-world data to enhance learning in financial modeling and healthcare investments.
- Industry Analysts: Gain insights into how medical technology companies like Inari Medical, Inc. (NARI) are valued in the market.
What the Template Contains
- Pre-Filled Data: Includes Inari Medical's historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Inari Medical's profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.